But investors appear to be rooting for Lilly: Shares of the drugmaker are up 9.35% this year, while Novo Nordisk is down 3.61% over the same time period
The biology is just as real
Commonly prescribed GLP-1 receptor agonists in the UK include: Semaglutide (Ozempic, Wegovy, Rybelsus [oral formulation]) Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) Exenatide (Byetta [twice-daily], Bydureon [weekly]) Tirzepatide (Mounjaro) - a dual GIP/GLP-1 receptor agonist with similar considerations [6] [7] These medications are typically administered via subcutaneous injection (daily, twice-daily or weekly depending on the specific formulation), with semaglutide also available as an oral tablet
In the last decade, formulations with extended release entered the market with once-weekly self-administrations pens
Following the standard escalation schedule, it takes approximately 20 weeks (about 5 months) to reach the 15 mg maximum dose from the 2.5 mg starting dose